A look back at a most successful therapeutic trial for Amyloidosis !
We are pleased to report that the trial is very promising and paves the way for a new therapy.
Amyloidosis is a group of rare diseases characterised by the abnormal deposition of amyloid proteins (proteins that misfold or twist to form “amyloid fibrils”) in various organs and tissues of…
Read MoreThe 4th European ATTR amyloidosis meeting for patients and physicians will be held on 2 and 3 November. To register, go online to the official event website: www.attramyloidosis2023.com It will…
Read MoreAmyloidosis is a recent disease, first described in 1838 by Rudolph Virchow, a German pathologist, who identified abnormal deposits in the tissue of deceased patients. Since then, much research has…
Read More